📈 TVRD Spike
October 13, 2025
Open Price
${{Model.Record.Open.ToString("0.00")}}
Close Price
${{Model.Record.Close.ToString("0.00")}}
Previous Close
${{Model.Record.PrevClose.ToString("0.00")}}
% Change
+-83.92%
📊Price Chart (14 Days)
📰Related News
8 articles
Tvardi Therapeutics Said Preliminary Data From Phase 2 REVERT Trial of TTI-101 In Idiopathic Pulmonary Fibrosis Show That The Study Did Not Meet Its Goals
benzinga • Oct 13, 2025 11:32 UTC
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga • Oct 13, 2025 12:09 UTC
Barclays Initiates Coverage On Tvardi Therapeutics with Overweight Rating, Announces Price Target of $61
benzinga • Oct 13, 2025 12:14 UTC
Dow Surges 1%; Fastenal Shares Fall After Q3 Results
benzinga • Oct 13, 2025 13:55 UTC
BTIG Maintains Buy on Tvardi Therapeutics, Lowers Price Target to $15
benzinga • Oct 13, 2025 15:37 UTC
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga • Oct 13, 2025 17:06 UTC
Gold Rises Over 3%; Tvardi Therapeutics Shares Plunge
benzinga • Oct 13, 2025 17:12 UTC
Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks
benzinga • Oct 13, 2025 18:23 UTC
🤖AI Classification
Classify news articles to understand market sentiment